Riviciclib

• Target:

  Others|||CDK

• Related Pathways:

  Cell Cycle/Checkpoint|||Others

• Bioactivity:

  Riviciclib is a potent inhibitor of cyclin-dependent kinase (CDK) (CDK9-cyclinT1, CDK4-cyclin D1, and CDK1-cyclinB with IC50s of 20 nM, 63 nM, and 79 nM, respectively), with antitumor activity on cisplatin-resistant cells.

• Smiles:

  OC=1C(=C2C(C(=O)C=C(O2)C3=C(Cl)C=CC=C3)=C(O)C1)[C@H]4[C@H](CO)N(C)CC4

• Molecular Formula:

  C21H20ClNO5

• Molecular Weight:

  401.84

• Shipping Conditions:

  Cool pack

• Storage Temperature:

  -20°C

• CAS Number:

  920113-02-6